High-dose chemotherapy followed by autologous stem cell transplantation for relapsed/refractory primary mediastinal large B-cell lymphoma

Affiliations

• ¹ Department of Hematology and Oncology, Nagoya Daini Red Cross Hospital, Nagoya, Japan.
• ² Department of Hematology and Oncology, Nagoya University Graduate School of Medicine, Nagoya, Japan.
• ³ Cancer Center, Shimane University Hospital, Izumo, Japan.
• ⁴ Department of Hematology, Toranomon Hospital, Tokyo, Japan.
• ⁵ Department of Hematology and Oncology, Okayama University Hospital, Okayama, Japan.
• ⁶ Department of Hematology, Endocrinology and Metabolism, Niigata University Faculty of Medicine, Niigata, Japan.
• ⁷ Department of Hematology and Oncology, Dokkyo Medical University School of Medicine, Tochigi, Japan.
• ⁸ Department of Hematology and Oncology, Gunma Cancer Center, Oota, Japan.
• ⁹ Department of Biomedical Laboratory Sciences, Shinshu University School of Medicine, Matsumoto, Japan.
• ¹⁰ Department of Hematology, Shinshu University School of Medicine, Matsumoto, Japan.
• ¹¹ Department of Hematology and Oncology, Mie University Graduate School of Medicine, Tsu, Japan.
• ¹² Department of Hematology, Hiroshima University Hospital, Hiroshima, Japan.
• ¹³ Department of Hematology, Tokai University, Isehara, Japan.
• ¹⁴ Department of Pathology, Tokai University, Isehara, Japan.
• ¹⁵ Department of Medical Oncology, Kanagawa Cancer Center, Yokohama, Japan.
• ¹⁶ Department of Pathology and Clinical Laboratories, Nagoya University Hospital, Nagoya, Japan.
• ¹⁷ Department of Hematology and Cell Therapy, Aichi Cancer Center, Nagoya, Japan.
• ¹⁸ Department of Hematology, Tokai Central Hospital, Kakamigahara, Japan.